Therapy of endocrine disease: the challenges in managing giant prolactinomas

D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - academic.oup.com
Giant prolactinomas are rare tumours, representing only 2–3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …
被引用次数：189 相关文章

[引用][C] The challenges in managing giant prolactinomas

D MAITER, E DELGRANGE - European journal of …, 2014 - pascal-francis.inist.fr
The challenges in managing giant prolactinomas CNRS Inist Pascal-Francis CNRS Pascal
and Francis Bibliographic Databases Simple search Advanced search Search by …

The challenges in managing giant prolactinomas.

D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - search.ebscohost.com
Giant prolactinomas are rare tumours, representing only 2-3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

Therapy of endocrine disease: the challenges in managing giant prolactinomas.

D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - dial.uclouvain.be
Giant prolactinomas are rare tumours, representing only 2-3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

Therapy of endocrine disease: the challenges in managing giant prolactinomas.

D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - europepmc.org
Giant prolactinomas are rare tumours, representing only 2-3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

THERAPY OF ENDOCRINE DISEASE: The challenges in managing giant prolactinomas

D Maiter, E Delgrange - European Journal of Endocrinology, 2014 - cir.nii.ac.jp
抄録< jats: p> Giant prolactinomas are rare tumours, representing only 2–3% of all prolactin
(PRL)-secreting tumours and raising special diagnostic and therapeutic challenges. Based …

Therapy of endocrine disease: the challenges in managing giant prolactinomas

D Maiter, E Delgrange - European journal of …, 2014 - pubmed.ncbi.nlm.nih.gov
Giant prolactinomas are rare tumours, representing only 2-3% of all prolactin (PRL)-
secreting tumours and raising special diagnostic and therapeutic challenges. Based on …

[引用][C] The challenges in managing giant prolactinomas

D MAITER, E DELGRANGE - European journal of endocrinology, 2014 - BioScientifica